xenotransplantation

xenotransplantation
Name	Xenotransplantation
MeshID	D014183

xenotransplantation is the transplantation of living cells, tissues, or organs from one species to another. This field represents a frontier in transplant surgery, aiming to address the critical shortage of human donor organs. It involves complex biological challenges, primarily the risk of hyperacute rejection mediated by the recipient's immune system. Research is heavily focused on genetically engineering source animals, particularly pigs, to make their tissues more compatible with human physiology.

Definition and Overview

The procedure involves sourcing biological material from a non-human species, known as a xenograft, for implantation into a human recipient. This approach is distinct from allotransplantation, which occurs between individuals of the same species. The primary goal is to provide a sustainable supply of organs, such as hearts, kidneys, and livers, to patients on waiting lists managed by organizations like the United Network for Organ Sharing. Key research institutions advancing this field include the University of Maryland Medical Center and the Massachusetts General Hospital.

Historical Development

Early attempts date back to the 17th century with blood transfusions using animal blood. The 20th century saw several high-profile experimental surgeries, such as the 1963 transplantation of a chimpanzee kidney into a patient by surgeon Keith Reemtsma at Tulane University. In 1984, the case of Baby Fae, who received a baboon heart at Loma Linda University Medical Center, garnered significant public attention. The development of immunosuppressive drugs like cyclosporine and advancements in genetic engineering, notably CRISPR-Cas9, have been pivotal in modern research.

Medical Applications and Procedures

Potential applications range from solid organ transplants to cellular therapies for conditions like diabetes mellitus using pancreatic islet cells. The most promising source animals are genetically modified pigs, with genes altered to reduce antigen expression, such as alpha-gal. Procedures often involve complex protocols to prevent rejection, potentially using immunosuppressants developed from research on human immunodeficiency virus drug therapies. Landmark surgeries include the 2022 procedure at the University of Maryland Medical Center where a patient received a genetically engineered pig heart.

Ethical and Safety Considerations

Major ethical debates are managed by bodies like the Nuffield Council on Bioethics and involve concerns about animal welfare, informed consent, and distributive justice. The primary safety issue is the risk of zoonosis, specifically the potential transmission of porcine endogenous retroviruses to human recipients, a concern highlighted by researchers at the Centers for Disease Control and Prevention. These considerations are often weighed against the mortality rates of patients awaiting transplants from the Organ Procurement and Transplantation Network.

Regulatory and Legal Framework

In the United States, oversight is primarily the responsibility of the Food and Drug Administration under the Public Health Service Act. The World Health Organization and the International Xenotransplantation Association provide global guidelines and consensus statements. Regulatory frameworks address stringent monitoring for infectious diseases, as outlined in documents from the European Medicines Agency. Legal issues concerning patient rights and liability are often informed by precedents set during the early AIDS epidemic.

Current Research and Future Directions

Ongoing research is led by companies like United Therapeutics and eGenesis, focusing on further genetic modifications in pigs using technologies like CRISPR-Cas9. Key areas include inducing immunological tolerance and preventing coagulopathy in transplanted organs. Future directions may involve the creation of chimerism through bone marrow transplantation, as explored in studies at Harvard Medical School. The long-term success of this field may fundamentally alter the work of the American Society of Transplant Surgeons.

Category:Transplant surgery Category:Medical genetics